Dr. Bishoy M. Faltas (@FaltasLab) header
Dr. Bishoy M. Faltas (@FaltasLab) profile picture

Physician-Scientist. Chief Research Officer @EngIPM. Gellert-John P. Leonard Scholar, Associate Professor @WeillCornell. Husband & father. RTs ≠ endorsements

Manhattan, NY
Joined February 2015
Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)Photo by Dr. Bishoy M. Faltas (@FaltasLab)
Thank you to @CBSNews for highlighting our #research! For many patients with muscle-invasive #BladderCancer, the standard of care is neoadjuvant systemic therapy followed by curative surgery to remove the bladder. For selected patients, bladder-preserving approaches are already an option, and the field is working to expand who can safely benefit. Our #research at @WeillCornell @nyphospital combines patient-derived cancer organoids with AI to create “bio-digital avatars” of each patient's cancer. This is team science, bringing together clinicians, laboratory scientists, computational biologists and mathematicians. We envision that these technologies could eventually help predict each patient’s response to treatment. Rigorous prospective validation will be essential before they can guide routine clinical care. @Cornell @WCMGUcancer @WCMEnglanderIPM @WCM_MeyerCancer @BladderCancerUS #FaltasLab
What if doctors could test cancer treatments on your tumor, without putting a single one of those treatments into your body? CBS News’ Riley Callanan reports.
11
23
6
75
21,739
Dr. Bishoy M. Faltas retweeted
Now online: A Germline-Encoded lncRNA–Mitochondrial Axis Rewires Oxidative Phosphorylation to Drive Progression in Clear-Cell Renal Cell Carcinoma doi.org/10.1158/0008-5472.CA…
1
1
342
Dr. Bishoy M. Faltas retweeted
New preprint: RB1-null #prostate cancer is addicted to E2F, but E2Fs resist direct drugging. All six typical E2Fs share a conserved minor intron, so blocking the minor spliceosome mis-splices the whole family at once, downstream of RB where CDK4/6 fails. bit.ly/4zPoTDq
9
30
3,036
Dr. Bishoy M. Faltas retweeted
Now online! Reconstructing developmental and disease progression with sample-level embeddings dlvr.​it/TWGGs0
1
9
38
6,200
Dr. Bishoy M. Faltas retweeted
Chromatin accessibility trajectories reveal pre-cancerous epigenetic priming and an acid-driven immunotherapy-resistant gastric cancer subtype dlvr.​it/TWGsF1
1
14
2
42
3,181
Dr. Bishoy M. Faltas retweeted
Now online: Tumor Cells Hijack Coagulation Signaling to Enable Immune Escape and Metastatic Dissemination doi.org/10.1158/0008-5472.CA…
1
332
Dr. Bishoy M. Faltas retweeted
How multimodal AI, combined with blood test omics via "liquid biopsies," will transform cancer monitoring and enable earliest detection. open-access @CellCellPress cell.com/cell/fulltext/S0092…
12
62
2
233
25,286
Dr. Bishoy M. Faltas retweeted
Lung neuroendocrine cancer induces immunosuppressive macrophages via serotonin to drive resistance to the T cell engager tarlatamab dlvr.​it/TWGGDQ
13
76
4,812
Congratulations to my postdoc @MHosmanMD @Regeneron @WeillCornell!
Honored to be featured in the Weill Cornell Hem/Onc 2026 newsletter as a @Regeneron Prize for Creative Innovation Finalist. Grateful to @WCMResearch and @HughHemmings for unwavering support, and to @FaltasLab, @DrScottTagawa, @ElementoLab, @DrDavidNanus for invaluable mentorship.
1
2
7
773
Dr. Bishoy M. Faltas retweeted
By analyzing a massive collection of #TCellReceptor chains from 150,000+ patient samples, researchers have developed a pipeline to accelerate the discovery and validation of public T cell receptors for immunotherapeutic design. @ScienceTM scim.ag/4zr7Ffb
2
9
32
15,201
Dr. Bishoy M. Faltas retweeted
Physician Leadership in a Changing Healthcare Environment. How can urology and oncology leaders drive innovation? @SWilliams_MD and @FaltasLab, discuss physician leadership in today's evolving healthcare environment. #Leadership #WatchNow > bit.ly/4dM6Cho @zklaassen_md
1
2
9
931
Dr. Bishoy M. Faltas retweeted
Excited to share our other recent paper in @NatureBiotech from Christina Leslie and our lab. We developed and in vivo validated DynaVelo, a deep learning tool that predicts rescue of genetic loss-of-function mutations. Brilliantly led by @karbalayghareh nature.com/articles/s41587-0…
4
18
89
7,862
Dr. Bishoy M. Faltas retweeted
Join or Renew Your ISUP Membership: isupweb.net/membership-join-…
📰 ISUP November 2026 Newsletter is out! 🔬 Stockholm Consensus Meeting highlights
🌍 Global outreach & new committees
📚 Education, mentorship & proficiency testing
🤝 Updates from CAP26 & IAP 2026 Read more: isupweb.net/isup-newsletter/
1
1
6
497